One platform. Three verticals.
RAPID was proven in shrimp because that's where our expertise lies. That proof now powers our expansion into fin fish, swine and beyond.
Shrimp
P. vannamei · P. monodon
Our beachhead vertical. RAPID was built for shrimp farming because it's one of the hardest diagnostic environments on earth — remote ponds, fast-acting pathogens, farms hours from any lab. Validated against qPCR. Deployed commercially across 9 countries.
6
Pathogens
9
Countries
<1 hour
Result
Fin Fish
Tilapia
Tilapia is the world's second most farmed aquatic animal. ISKNV, TiLV, and Streptococcus cost the industry hundreds of millions annually — and on-site molecular diagnostics simply don't exist for most farms. We're building them.
6
Targets
2026 Q3
Target launch
SEA
Primary market
Swine
ASF has cost Southeast Asia over $130B since 2018. The only containment strategy is early detection — and most farms still rely on centralised labs. The RAPID ASF assay is live now. PRRS and FMD are in the pipeline.
ASF
Available now
2
More in pipeline
SEA
Primary market
Have a pathogen we haven't listed?
The RAPID platform is open by design. If you have a target pathogen, a species, or a use case we haven't covered yet, we want to hear from you.